Simone Olgiati PhD Merck
Simone Olgiati PhD Merck Head of Molecular Biology Technology & Innovation
Dr. Simone Olgiati is head of the Molecular Biology Technology & Innovation Unit, leading a team of scientists and bioinformaticians within the Healthcare sector of Merck. This unit applies a solid expertise on advanced molecular methods to support the manufacturing and quality control of biotechnological products by developing and validating innovative analytical methods for a variety of applications, mostly in the fields of viral safety and genetic characterization. Dr. Olgiati holds a MSc in Biology from the University of Insubria (Italy) and a PhD in Human Genetics from the Erasmus Medical Center (the Netherlands). Before moving to Merck (Italy) in 2019, he held a bioinformatic position at Cergentis, building competencies on the genetic analysis of recombinant cell lines with the TLA technology. Moreover, he served as bioinformatician at BlueBee (lately part of Illumina), focusing on diagnostic analyses of NGS data in cloud-based environments. His professional journey allowed him to develop expertise in Big Data analytics and a broad view of NGS applications in both diagnostics and industry.